These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36319182)

  • 1. [Survival and prognosis analysis of patients with Hodgkin lymphoma treated with standard treatment paradigm].
    Shi YK; Tao XH; He Y; Qin P; Liu ST; Zhou JL; Yang LJ; Zhou YW; Song SL; Wang J; Jin H; Fang YP; Liu Y; Zhang SN; Qi Y; Yang CG; Zhang C; Yang L; Gui L
    Zhonghua Yi Xue Za Zhi; 2022 Nov; 102(41):3295-3303. PubMed ID: 36319182
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical characteristics and treatment outcomes of Chinese diffuse large B-cell lymphoma patients in the era of rituximab (2005-2018).
    Shi Y; Chen H; Qin Y; Yang J; Liu P; He X; Zhou S; Zhou L; Zhang C; Song Y; Liu Y; Gui L; Wang S; Jin J; Fang H; Qi S; Li N; Tang Y; Wang X; Yang S
    Cancer Pathog Ther; 2023 Jan; 1(1):3-11. PubMed ID: 38328609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased Prognostic Value of International Prognostic Score in Chinese Advanced Hodgkin Lymphoma Patients Treated in the Contemporary Era.
    Wang Q; Qin Y; Kang SY; He XH; Liu P; Yang S; Zhou SY; Zhang CG; Gui L; Yang JL; Sun Y; Shi YK
    Chin Med J (Engl); 2016 Dec; 129(23):2780-2785. PubMed ID: 27900988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapsed hodgkin lymphoma in older patients: a comprehensive analysis from the German hodgkin study group.
    Böll B; Goergen H; Arndt N; Meissner J; Krause SW; Schnell R; von Tresckow B; Eichenauer DA; Sasse S; Fuchs M; Behringer K; Klimm BC; Naumann R; Diehl V; Engert A; Borchmann P
    J Clin Oncol; 2013 Dec; 31(35):4431-7. PubMed ID: 24190119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma.
    Blank O; von Tresckow B; Monsef I; Specht L; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD007110. PubMed ID: 28447341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary Outcomes for Advanced-Stage Classical Hodgkin Lymphoma in the U.S.: Analysis of Surveillance, Epidemiology, and End Results Database.
    Guru Murthy GS; Szabo A; Hamadani M; Fenske TS; Shah NN
    Oncologist; 2019 Nov; 24(11):1488-1495. PubMed ID: 31467178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A analysis of the outcome and prognostic factors in 415 patients with Hodgkin lymphoma].
    Tao Y; Kang S; Zhou L; Shi Y; Li Y; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):466-71. PubMed ID: 26463153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma.
    Rancea M; Monsef I; von Tresckow B; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009411. PubMed ID: 23784872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A Real-World Single-Center Study of Adult Hodgkin's Lymphoma].
    Wang LL; Tian L; Dong F; Yang P; Wan W; Li QH; Ma L; Gao JJ; Wang JJ; Zhao W; Jing HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):428-433. PubMed ID: 38660847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term results of high-dose chemotherapy with autologous bone marrow or peripheral stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin lymphoma: a single institution experience.
    Viviani S; Di Nicola M; Bonfante V; Di Stasi A; Carlo-Stella C; Matteucci P; Magni M; Devizzi L; Valagussa P; Gianni AM
    Leuk Lymphoma; 2010 Jul; 51(7):1251-9. PubMed ID: 20528244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of salvage radiation therapy for patients with relapsed or refractory hodgkin lymphoma who failed autologous stem cell transplant.
    Goda JS; Massey C; Kuruvilla J; Gospodarowicz MK; Wells W; Hodgson DC; Sun A; Keating A; Crump M; Tsang RW
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e329-35. PubMed ID: 22672755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study.
    Castillo JJ; Bower M; Brühlmann J; Novak U; Furrer H; Tanaka PY; Besson C; Montoto S; Cwynarski K; Abramson JS; Dalia S; Bibas M; Connors JM; Furman M; Nguyen ML; Cooley TP; Beltran BE; Collins JA; Vose JM; Xicoy B; Ribera JM;
    Cancer; 2015 Feb; 121(3):423-31. PubMed ID: 25251326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A multicenter study on childhood Hodgkin lymphoma treated with HL-2013 regimen in China].
    Nie DM; Yuan Q; Yu Y; Wu CJ; Guo X; Zhang AJ; Wang J; Xiao LY; Weng KZ; Fang YJ; Ju XL; Gao J; Xu ZJ; Yang LC; Liu AG; Gao YJ
    Zhonghua Er Ke Za Zhi; 2022 Nov; 60(11):1172-1177. PubMed ID: 36319153
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparison of follow-up treatment regimens for colorectal cancer liver metastases without objective response to neoadjuvant chemotherapy: direct surgery or surgery after second-line chemotherapy].
    Lyu XY; Bi XY; Zhao H; Chen QC; Luo ZW; Zhang BL; Zhang XS; Cai JQ
    Zhonghua Wai Ke Za Zhi; 2022 May; 60(5):454-460. PubMed ID: 35359087
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials.
    Sasse S; Bröckelmann PJ; Goergen H; Plütschow A; Müller H; Kreissl S; Buerkle C; Borchmann S; Fuchs M; Borchmann P; Diehl V; Engert A
    J Clin Oncol; 2017 Jun; 35(18):1999-2007. PubMed ID: 28418763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome analysis of high-dose chemotherapy and autologous stem cell transplantation in adolescent and young adults with relapsed or refractory Hodgkin lymphoma.
    Akhtar S; Rauf SM; Elhassan TA; Maghfoor I
    Ann Hematol; 2016 Sep; 95(9):1521-35. PubMed ID: 27376363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors and a prognostic score for survival after autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma.
    Bröckelmann PJ; Müller H; Casasnovas O; Hutchings M; von Tresckow B; Jürgens M; McCall SJ; Morschhauser F; Fuchs M; Borchmann P; Moskowitz CH; Engert A
    Ann Oncol; 2017 Jun; 28(6):1352-1358. PubMed ID: 28327958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of Patients With Second Primary Hodgkin Lymphoma.
    Budnik J; Doucette C; Milano MT; Constine LS
    Clin Lymphoma Myeloma Leuk; 2020 May; 20(5):316-323.e2. PubMed ID: 32014390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma.
    Majhail NS; Weisdorf DJ; Defor TE; Miller JS; McGlave PB; Slungaard A; Arora M; Ramsay NK; Orchard PJ; MacMillan ML; Burns LJ
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1065-72. PubMed ID: 17084370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma].
    Mao L; Wang X; Wang CY; Xia B; Ning QY; Yang HL; Yu Y; Zhang YZ
    Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1853-1858. PubMed ID: 31269579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.